VICH 4 Photos |
| June
24 & 25, 2010 (including Gala Dinner at Le Lido) |
|
| Final presentations
delivered at the VICH 4 Conference at OIE (Paris,
France) |
|
| Plenary Session I |
| VICH
- where are we? VICH Phase I and II: strategy and
achievements (H. Marion, VICH
Secretariat) |
| The
needs and expectations of regulatory authorities outside the
VICH regions (I. Daré, UEMOA -
West Africa Region) |
| The
administration of veterinary drug in China and views on VICH
from China (W. Duan & S. Xu,
China Institute of Veterinary Drug Control) |
| The
needs and expectations of a global industry (E.
Marée, Virbac & IFAH Board President) |
|
| Workshops
Stream 1: Impact of VICH GLs and future topics |
| Safety
Expert Working Group (Chair: K.
Greenlees - Rapporteur: G. Schmuck) |
| Pharmacovigilance
Expert Working Group (Chair: L.
Post - Rapporteur: E. De Ridder) |
| Biological
Quality Monitoring (BQM) Expert Working Group (Chair:
K. Oishi - Rapporteur: J. Hogan) |
| Metabolism
and Residue Kinetics (MRK) Expert Working Group (Chair:
S. Scheid - Rapporteur: D. Gottschall) |
| Quality,
Efficacy and ERA Expert Working Groups (Chair:
P. Holdsworth - Rapporteur: M. Fisher) |
| Microbiological
ADI Expert Working Group (Chair:
H. Fernandez - Rapporteur: P. Silley) |
|
| Workshops Stream
2: VICH as global partner |
Global environment
for veterinary medicines
Chair: A.K. Pradhan (Indian Authority) -
Rapporteur: B. Dungu (GALVmed) |
| OIE
strategy and role in animal health (P.
Dehaumont, OIE, AFSSA/ANMV) |
| Role
of Codex and JECFA (S. Vaughn, US
FDA/Center for Veterinary Medicine) |
| Role
of VICH (D. Mackay, European
Medicines Agency) |
|
Plans for VICH Global
Outreach
Chair: C. Shuey (AAHA) - Rapporteur: H.
Schneider (AGRIVET, Namibia) |
| Proposal
for a VICH Global Outreach (P.
Dehaumont, OIE, AFSSA/ANMV) |
|
Value
and Future Vision (VICH Phase III)
Chair: K. Grein (European Medicines Agency) -
Rapporteur: M. Smith (US FDA) |
|
| Plenary Session
II: Reports from Stream 1 Workshops |
| See above |
|
Plenary Session
III: Reports from Stream 2
Workshops
Chair: M. Eloit (Deputy
Director General OIE) |
| Global
environment for veterinary medicines (B.
Dungu, GALVmed) |
| Plans
for VICH Global Outreach (AGRIVET,
Namibia) |
| Value
and Future Vision (M. Smith, US
FDA) |
|
|
Plenary Session IV: Benefits and Impact of the VICH
Initiative and spreading the word |
| Chair: M. Smith (US FDA) - Presentation |
|
Plenary Session V:
VICH - The Vision
for the Future
Chair: B. Freischem (IFAH
Executive Director) |
| The
Progress of ICH (M. Limoli, US FDA) |
| How
can VICH be inspired from the evolutions in ICH?
(M. Terberger, European Commission) |
| VICH
Phase III 2011-2015 - future opportunities (B.
Boenisch, Merial - IFAH-Europe) |
|
Conclusion
of the Conference
D. Mackay (European Medicines
Agency) |
